Jazz Pharmaceuticals Statistics
Total Valuation
JAZZ has a market cap or net worth of $6.81 billion. The enterprise value is $10.96 billion.
| Market Cap | 6.81B |
| Enterprise Value | 10.96B |
Important Dates
The next confirmed earnings date is Wednesday, May 1, 2024, after market close.
| Earnings Date | May 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
JAZZ has 62.35 million shares outstanding. The number of shares has increased by 15.23% in one year.
| Shares Outstanding | 62.35M |
| Shares Change (YoY) | +15.23% |
| Shares Change (QoQ) | -2.28% |
| Owned by Insiders (%) | 2.82% |
| Owned by Institutions (%) | 95.96% |
| Float | 60.45M |
Valuation Ratios
The trailing PE ratio is 17.91 and the forward PE ratio is 5.63. JAZZ's PEG ratio is 0.84.
| PE Ratio | 17.91 |
| Forward PE | 5.63 |
| PS Ratio | 1.78 |
| Forward PS | 1.63 |
| PB Ratio | 1.82 |
| P/FCF Ratio | 6.38 |
| PEG Ratio | 0.84 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.96, with an EV/FCF ratio of 10.26.
| EV / Earnings | 26.42 |
| EV / Sales | 2.86 |
| EV / EBITDA | 8.96 |
| EV / EBIT | 18.75 |
| EV / FCF | 10.26 |
Financial Position
The company has a current ratio of 2.24, with a Debt / Equity ratio of 1.54.
| Current Ratio | 2.24 |
| Quick Ratio | 1.52 |
| Debt / Equity | 1.54 |
| Debt / EBITDA | 4.72 |
| Debt / FCF | 5.40 |
| Interest Coverage | 2.02 |
Financial Efficiency
Return on equity (ROE) is 11.80% and return on invested capital (ROIC) is 8.56%.
| Return on Equity (ROE) | 11.80% |
| Return on Assets (ROA) | 3.70% |
| Return on Capital (ROIC) | 8.56% |
| Revenue Per Employee | $1.37M |
| Profits Per Employee | $148,154 |
| Employee Count | 2,800 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 0.66 |
Taxes
| Income Tax | -119.91M |
| Effective Tax Rate | -40.66% |
Stock Price Statistics
The stock price has decreased by -23.89% in the last 52 weeks. The beta is 0.61, so JAZZ's price volatility has been lower than the market average.
| Beta (1Y) | 0.61 |
| 52-Week Price Change | -23.89% |
| 50-Day Moving Average | 120.05 |
| 200-Day Moving Average | 125.96 |
| Relative Strength Index (RSI) | 33.26 |
| Average Volume (30 Days) | 620,809 |
Short Selling Information
The latest short interest is 3.26 million, so 5.23% of the outstanding shares have been sold short.
| Short Interest | 3.26M |
| Short Previous Month | 2.77M |
| Short % of Shares Out | 5.23% |
| Short % of Float | 5.40% |
| Short Ratio (days to cover) | 3.98 |
Income Statement
In the last 12 months, JAZZ had revenue of $3.83 billion and earned $414.83 million in profits. Earnings per share was $6.10.
| Revenue | 3.83B |
| Gross Profit | 3.40B |
| Operating Income | 578.58M |
| Pretax Income | 294.92M |
| Net Income | 414.83M |
| EBITDA | 1.22B |
| EBIT | 584.36M |
| Earnings Per Share (EPS) | $6.10 |
Balance Sheet
The company has $1.63 billion in cash and $5.77 billion in debt, giving a net cash position of -$4.15 billion or -$66.50 per share.
| Cash & Cash Equivalents | 1.63B |
| Total Debt | 5.77B |
| Net Cash | -4.15B |
| Net Cash Per Share | -$66.50 |
| Equity / Book Value | 3.74B |
| Book Value Per Share | 59.94 |
| Working Capital | 1.90B |
Cash Flow
In the last 12 months, operating cash flow was $1.09 billion and capital expenditures -$23.96 million, giving a free cash flow of $1.07 billion.
| Operating Cash Flow | 1.09B |
| Capital Expenditures | -23.96M |
| Free Cash Flow | 1.07B |
| FCF Per Share | $16.88 |
Margins
Gross margin is 88.64%, with operating and profit margins of 15.09% and 10.82%.
| Gross Margin | 88.64% |
| Operating Margin | 15.09% |
| Pretax Margin | 7.69% |
| Profit Margin | 10.82% |
| EBITDA Margin | 31.90% |
| EBIT Margin | 15.24% |
| FCF Margin | 27.86% |
Dividends & Yields
JAZZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.23% |
| Shareholder Yield | -15.23% |
| Earnings Yield | 6.09% |
| FCF Yield | 15.68% |
Analyst Forecast
The average price target for JAZZ is $193.43, which is 77.02% higher than the current price. The consensus rating is "Buy".
| Price Target | $193.43 |
| Price Target Difference | 77.02% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 4.49% |
| EPS Growth Forecast (5Y) | 29.30% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
JAZZ has an Altman Z-Score of 1.35 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.35 |
| Piotroski F-Score | 7 |